Your browser doesn't support javascript.
loading
Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3.
Nagai, Kozo; Hou, Lihong; Li, Li; Nguyen, Bao; Seale, Tessa; Shirley, Courtney; Ma, Hayley; Levis, Mark; Ghiaur, Gabriel; Duffield, Amy; Small, Donald.
Afiliação
  • Nagai K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hou L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Li L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Nguyen B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Seale T; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Shirley C; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ma H; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Levis M; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ghiaur G; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Duffield A; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Small D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Oncotarget ; 9(68): 32885-32899, 2018 Aug 31.
Article em En | MEDLINE | ID: mdl-30250637

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos